GlycoPure
Cambridge
About GlycoPure
GlycoPure, Inc. is a development-stage, Maryland-based C-Corporation established to develop and commercialize a novel process for producing superior quality glucosamine, and related products, at a significant cost advantage and in an environmentally safe manner. This process is based on proprietary technology that the Company has licensed from The Johns Hopkins University. This technology is centered on a genetically-modified bacterium which produces pure forms of glucosamine and N-acetylglucosamine from chitin-containing materials. The glucosamine can be reacted with a variety of acids to form the products common in the market (i.e. GlcHCl).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Equity Crowdfunding (Oct 2010)
Industries & Categories
Biotechnology, Manufacturing, Medical
Canonical: https://fsome.com/organization/glycopure-3331167 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.